FDA Approves Vosoritide for Children With Achondroplasia

Vosoritide is a daily injection for children with achondroplasia who have open epiphyses, given under the skin and administered by a caregiver.

Related Keywords

Australia ,Japan ,Brazil ,William Wilcox ,European Society For Paediatric Endocrinology Meeting ,Emory University ,Biomarin Pharmaceutical Inc ,Paediatric Endocrinology Meeting ,European Medicines Agency ,Medicinal Products ,Human Use ,